The present study showed that the MVD labeled with CD105 was inversely correlated with BAI1 expression, indicating that BAI1 may be used as a marker of decreased tumoral neovascularization in human astrocytomas. Here, ADGRB1 is linked to astrocytoma (excluding glioblastoma).